Tag: albumin market size

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Anticipated CAGR of the Albumin Market, and What Factors Will Drive It?

The scale of the albumin market has seen substantial expansion in the past few years. It is projected to rise from $6.57 billion in 2024 to approximately $7.18 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.3%. The expansion seen during the historical timeframe is linked to progression in biotechnology, ascending demand for therapies derived from plasma, widening use in the pharmaceutical sector, high incidence of liver disorders, regulatory sanctioning of albumin-based goods, and an increasingly globalized healthcare system that allows for broader market reach.

The market size of albumin is projected to witness robust expansion in the upcoming years, with predictions showing growth to $10.16 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 9.1%. Factors contributing to this growth during the forecast period include a rise in liver disease cases, usage in regenerative medicine, a growing elderly populace, advancements in diagnostic methods, a tilt in healthcare structure towards outpatient care, and an increasing understanding of the necessity of maintaining ideal protein levels. Prominent trends for the predicted timeline include wider therapeutic usage, increased implementation in drug delivery systems, escalating demand in cell culture media, progress in personalized medicine, breakthroughs in recombinant technology, heightened awareness about managing hypoalbuminemia, and noteworthy investments in researching and developing state-of-the-art albumin-based solutions.

Which Factors Are Enhancing the Growth of the Albumin Market?

The growth of the albumin market is anticipated to be driven by the increasing prevalence of diabetes. Diabetes is a metabolic disorder characterized by persistent high levels of blood sugar. Contributing factors to the surge in diabetes cases include poor nutrition, insufficient physical activity, hormonal imbalances, and obesity. In the context of diabetes, albumin serves as a crucial biomarker, informing insulin therapy, tracking glycemic control, assisting in diagnosis, and forecasting complications like diabetic ketoacidosis (DKA). It is vital to maintain normal albumin levels for comprehensive diabetes management. For example, in January 2022, the National Library of Medicine, a government library in the US, reported that in 2021, the worldwide prevalence of diabetes was estimated at 10.5%, affecting roughly 536.6 million people aged between 20 and 79. This number is expected to rise to 12.2% by 2045, affecting about 783.2 million individuals. Therefore, the increasing prevalence of diabetes is likely to accelerate the growth of the albumin market.

Explore Comprehensive Insights Into The Global Albumin Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16333&type=smp

Who Are the Top Companies Contributing to the Growth of the Albumin Market?

Major companies operating in the albumin market are:

• Bristol-Myers Squibb Company

• Thermo Fisher Scientific Inc.

• Takeda Pharmaceutical Company Limited

• Merck KGaA

• Baxter International Inc.

How Are Technological Trends Affecting the Growth and Development of the Albumin Market?

In the albumin market, principal corporations are focusing on the invention of cutting-edge products such as animal- and human-origin-free recombinant albumin to meet the progressive needs of its users. Recombinant albumin free from animal and human origin implies albumin produced through non-mammalian expression systems like yeast, excluding any elements from animals or humans. A particular example is the collaboration between Albumedix, a UK-based recombinant human albumin (rHA) producer, and Heartseed Inc., a Japanese biotech firm in its clinical phase, in March 2023, to introduce Recombin. This essential excipient is used in the creation of Heartseed’s experimental cell therapy, HS-001, as its pioneer human clinical trial starts. This joint venture is a critical leap in the evolution of HS-001, predicted to significantly alter the curing process for multiple diseases. Incorporating recombination in the production process ensures superior stability and performance of the cell therapy, thereby enhancing its likelihood of therapeutic triumph.

Secure Your Global Albumin Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/albumin-global-market-report

Which Growth-Oriented Segments of the Albumin Market Are Leading the Industry’s Development?

The albumin market covered in this report is segmented –

1) By Type: Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin

2) By Application: Therapeutics, Drug Formulation And Vaccines, Component Of Media, Other Applications

3) By Sales Channel: Business-To-Consumer (B2C), Business-To-Business (B2B)

4) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Research Institutes

Subsegments:

1) By Human Serum Albumin: Plasma-Derived Human Serum Albumin, Recombinant Human Serum Albumin, Human Serum Albumin For Therapeutic Use (In Liver Disease, Burns), Human Serum Albumin For Drug Delivery And Research Applications

2) By Bovine Serum Albumin: Bovine Serum Albumin For Laboratory Use (In Cell Culture), Bovine Serum Albumin For Diagnostic Kits, Bovine Serum Albumin As A Stabilizer In Vaccines And Biopharmaceuticals

3) By Recombinant Albumin: Recombinant Human Albumin For Therapeutic Applications, Recombinant Albumin For Biopharmaceutical Formulation, Recombinant Albumin For Cosmetic And Personal Care Applications, Recombinant Albumin For Research And Diagnostic Applications

What Are the Key Regions Powering Growth in the Albumin Market?

North America was the largest region in the albumin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albumin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Albumin Market Defined Across Different Regions?

Albumin is a type of protein found in blood plasma, serum, muscle, the whites of eggs, milk, and other animal substances, as well as in many plant tissues and fluids. It is a simple, heat-coagulable, and water-soluble protein that plays a crucial role in maintaining fluid balance and transporting hormones, vitamins, and enzymes throughout the body.

Browse Through More Similar Reports By The Business Research Company:

Stem Cell Assay Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

Metagenomics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report

Glycomics or Glycobiology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

 

How Much Growth is Expected for the Albumin Market from 2024 to 2033?

The albumin market has experienced significant growth. It is expected to rise from $6.03 billion in 2023 to $6.57 billion in 2024, at a CAGR of 9.0%. The historical growth can be attributed to advancements in biotechnology, rising demand for plasma-derived therapies, expanding pharmaceutical applications, the high prevalence of liver diseases, regulatory approvals for albumin products, and the globalization of healthcare providing broader market access.

The albumin market is expected to grow substantially, reaching $9.33 billion by 2028 at a CAGR of 9.1%. This growth is driven by liver disease prevalence, regenerative medicine applications, the aging population, advanced diagnostic techniques, outpatient care shifts, and protein level awareness. Major trends include expanding therapeutic applications, drug delivery system adoption, cell culture media demand, personalized medicine growth, and R&D investments in innovative products.

 

Claim Your Free Sample of the Global Albumin Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=16333&type=smp

 

What Factors Are Encouraging Growth in the Albumin Market?

The albumin market is expected to grow due to the rising incidence of diabetes. Diabetes, characterized by prolonged high blood sugar levels, is increasing due to poor nutrition and obesity. Albumin serves as a vital biomarker in diabetes management, aiding in insulin therapy and monitoring glycemic control. For example, in January 2022, the National Library of Medicine estimated that global diabetes prevalence was around 10.5%, affecting 536.6 million individuals. By 2045, this is projected to rise to 12.2%, impacting approximately 783.2 million people. Therefore, the growing incidence of diabetes is expected to propel the albumin market.

 

Which Segments Play a Vital Role in the Albumin Market?

1) By Type: Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin

2) By Application: Therapeutics, Drug Formulation And Vaccines, Component Of Media, Other Applications

3) By Sales Channel: Business-To-Consumer (B2C), Business-To-Business (B2B)

4) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Research Institutes

 

What Trends Are Driving Change in the Albumin Market?

Companies in the albumin market are innovating with products like animal- and human-origin-free recombinant albumin. In March 2023, Albumedix from the UK and Heartseed Inc. from Japan collaborated to launch Recombin, a crucial excipient for Heartseed’s cell therapy, marking a significant advancement in treatment efficacy.

 

Order Now for Fast Delivery of Your Albumin Market Report!

https://www.thebusinessresearchcompany.com/report/albumin-global-market-report

 

What Regions Are Contributing Significantly to the Growth of the Albumin Market?

North America was the largest region in the albumin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albumin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Albumin Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the albumin market, its market share, and analyzes key competitors along with their market positions.

 

The Table Of Content For The Albumin Market Include

1. Albumin Market Executive Summary

2. Albumin Market Segments

3. Albumin Market Size And Template Market Growth Rate

4. Key Albumin Market Trends

5. Major Albumin Market Drivers

……

25. Key Mergers And Acquisitions In The Albumin Market

26. Top Albumin Companies

27. Albumin Market Opportunities And Strategies

28. Albumin Market, Conclusions And Recommendations

29. Appendix

 

Discover Related Reports by The Business Research Company:

Stem Cell Assay Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

Glycomics or Glycobiology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

Hospital Capacity Management Solutions Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hospital-capacity-management-solutions-global-market-report

 

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

 

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

 

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Albumin Global Market Report 2024, the albumin market is expected to show significant growth in the forecast period.

The albumin market has experienced significant growth in recent years and is poised for continued expansion. With a compound annual growth rate (CAGR) of 9.0% from 2023 to 2024, the market is set to increase from $6.03 billion in 2023 to $6.57 billion in 2024. This article delves into the key drivers of this growth, major trends shaping the market, and future projections.

Key Drivers of Albumin Market Growth

• Advancements in Biotechnology: Innovations in biotechnology have played a crucial role in driving the albumin market. The development of new albumin-based products and therapies has expanded the market’s reach.
• Increased Demand for Plasma-Derived Therapies: Plasma-derived therapies are essential in treating a variety of medical conditions. The growing demand for these therapies has significantly contributed to the expansion of the albumin market.
• High Prevalence of Liver Diseases: Liver diseases remain a leading cause of morbidity and mortality worldwide. The high prevalence of these conditions has led to an increased demand for albumin, further propelling market growth.
• Regulatory Approvals: The regulatory landscape has been favorable, with numerous approvals for albumin-based products. This has facilitated market expansion by allowing new products to reach consumers more quickly.
• Globalization of Healthcare: The globalization of healthcare has made advanced treatments and therapies more accessible, leading to wider market access for albumin products.

View More On The Albumin Market Report 2024 – https://www.thebusinessresearchcompany.com/report/albumin-global-market-report

Future Growth Projections and Trends
The albumin market is expected to continue its upward trajectory, reaching $9.33 billion by 2028, with a CAGR of 9.1%. Several factors will drive this growth:

• Increasing Prevalence of Liver Diseases: The rising incidence of liver diseases will continue to drive demand for albumin, particularly in therapeutic applications.
• Expanding Applications in Regenerative Medicine: Albumin is increasingly being used in regenerative medicine, a field that is growing rapidly and promises to significantly boost market demand.
• Rising Geriatric Population: As the global population ages, the need for albumin in various medical applications, including diagnostics and treatment, will increase.
• Evolving Diagnostic Techniques: Advances in diagnostic techniques that utilize albumin will further drive market growth, particularly in outpatient care settings.
• Personalized Medicine and Recombinant Technology: The shift towards personalized medicine and advancements in recombinant technology are creating new opportunities for albumin-based products.

Impact of Rising Diabetes Incidence
The growing incidence of diabetes is a significant factor in the albumin market’s expansion:

• Biomarker in Diabetes Management: Albumin is a critical biomarker in managing diabetes, guiding insulin therapy, monitoring glycemic control, and aiding in the diagnosis of complications like diabetic ketoacidosis (DKA).
• Global Diabetes Prevalence: With diabetes affecting 536.6 million people globally in 2021, and this number expected to rise to 783.2 million by 2045, the demand for albumin in diabetes management will continue to grow.

Innovations in Recombinant Albumin
Innovation is a key trend in the albumin market:

• Animal- and Human-Origin-Free Recombinant Albumin: Companies are developing recombinant albumin products that are free from animal and human origins, ensuring higher safety and efficacy. For instance, the collaboration between Albumedix and Heartseed Inc. in March 2023 to launch Recombin is a significant development in this space.

Strategic Acquisitions
Acquisitions are shaping the competitive landscape of the albumin market:

• Sartorius AG’s Acquisition of Albumedix: In September 2022, Sartorius AG acquired Albumedix, enhancing its presence in the advanced therapies and vaccines sector. This acquisition strengthens Sartorius’ offerings in cell culture media and process solutions, positioning it for further growth.

Market Segmentation
The albumin market is segmented based on:

• Type: Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin
• Application: Therapeutics, Drug Formulation and Vaccines, Component of Media, Other Applications
• Sales Channel: Business-To-Consumer (B2C), Business-To-Business (B2B)
• End-User: Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Research Institutes

Regional Insights

• North America: The largest region in the albumin market in 2023, driven by advanced healthcare infrastructure and high demand for albumin products.
• Asia-Pacific: Expected to be the fastest-growing region in the forecast period, fueled by increasing healthcare spending and growing awareness of albumin’s therapeutic benefits.

The albumin market is set for strong growth, driven by technological advancements, expanding applications, and strategic industry movements. As the market evolves, it will continue to play a crucial role in modern healthcare.

Request A Sample Of The Global Albumin Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16333&type=smp